NASDAQ:IBB - iShares Nasdaq Biotechnology ETF Stock Price, Forecast & News

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF announced a quarterly dividend on Monday, December 16th. Investors of record on Tuesday, December 17th will be paid a dividend of $0.0578 per share on Friday, December 20th. This represents a $0.23 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date is Monday, December 16th. View iShares Nasdaq Biotechnology ETF's Dividend History.

iShares Nasdaq Biotechnology ETF's stock split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Media headlines about IBB stock have trended positive on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a news impact score of 3.0 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for iShares Nasdaq Biotechnology ETF.

Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Hercules Capital (HTGC), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF), PIMCO High Income Fund (PHK), General American Investors (GAM) and Blackrock Muniyield Insured Fund (MYI).

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Bank of America (BAC), Walt Disney (DIS), Tesla (TSLA), Gilead Sciences (GILD), Cisco Systems (CSCO), JPMorgan Chase & Co. (JPM) and First Solar (FSLR).

iShares Nasdaq Biotechnology ETF's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Janney Capital Management LLC (0.31%), SG Americas Securities LLC (0.20%), Dowling & Yahnke LLC (0.14%), Valicenti Advisory Services Inc. (0.13%), Janney Montgomery Scott LLC (0.12%) and Neville Rodie & Shaw Inc. (0.10%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Moors & Cabot Inc., Diligent Investors LLC, Kistler Tiffany Companies LLC, Institute for Wealth Management LLC., CWM LLC, Winfield Associates Inc. and Dowling & Yahnke LLC.

IBB stock was purchased by a variety of institutional investors in the last quarter, including Janney Capital Management LLC, CHURCHILL MANAGEMENT Corp, Mirador Capital Partners LP, Calamos Advisors LLC, Bay Rivers Group, Tocqueville Asset Management L.P., SG Americas Securities LLC and Alpha Cubed Investments LLC.

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $117.32.

iShares Nasdaq Biotechnology ETF has a market capitalization of $7.36 billion. View Additional Information About iShares Nasdaq Biotechnology ETF.